Option Care Health, Inc. OPCH
Option Care Health, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6B | $5.0B | $4.3B | $3.9B | $3.4B | $3.0B | $2.3B | $1.9B | $1.8B | $935.6M |
| Gross profit | $1.1B | $1.0B | $981.2M | $866.9M | $779.6M | $682.3M | $513.0M | $422.2M | $446.0M | $262.1M |
| SG&A expense | $682.5M | $630.3M | $607.4M | $566.1M | $525.7M | $500.2M | $459.6M | $345.9M | $338.5M | — |
| Operating income | $337.9M | $321.8M | $314.6M | $240.2M | $190.8M | $110.8M | -$319,000 | $38.3M | $27.3M | -$11.0M |
| Interest expense | — | — | $51.2M | $53.8M | $67.0M | $107.8M | $73.7M | $45.8M | — | — |
| Income tax | $75.3M | $71.8M | $91.7M | $55.2M | -$23.4M | $2.8M | -$2.3M | -$2.7M | -$18.6M | $2.0M |
| Net income | $207.6M | $211.8M | $267.1M | $150.6M | $139.9M | -$8.1M | -$75.9M | -$6.1M | $3.9M | -$42.8M |
| EPS (diluted) | $1.27 | $1.23 | $1.48 | $0.83 | $0.77 | $-0.04 | $-0.49 | — | — | — |
| Operating cash flow | $258.4M | $323.4M | $371.3M | $267.5M | $208.6M | $127.4M | $39.5M | $24.4M | $37.9M | -$42.5M |
| Free cash flow | $217.1M | $287.8M | $329.4M | $232.2M | $182.9M | $100.5M | $11.2M | -$1.8M | $12.9M | — |
| Cash & equivalents | $232.6M | $412.6M | $343.8M | $294.2M | $119.4M | $99.3M | $67.1M | $36.4M | $39.5M | $9.6M |
| Inventory | $471.1M | $388.1M | $274.0M | $224.3M | $183.1M | $158.6M | $115.9M | $83.3M | $38.0M | $36.2M |
| Total assets | $3.5B | $3.4B | $3.2B | $3.1B | $2.8B | $2.6B | $2.6B | $1.4B | $603.1M | $605.0M |
| Total liabilities | $2.1B | $2.0B | $1.8B | $1.7B | $1.6B | $1.6B | $1.7B | $825.4M | $605.8M | $566.6M |
| Shareholders' equity | $1.3B | $1.4B | $1.4B | $1.4B | $1.2B | $1.0B | $906.8M | $602.8M | $606.1M | $600.8M |
Growth · year-over-year · Revenue CAGR 22.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +13.0% | +16.2% | +9.1% | +14.7% | +13.4% | +31.3% | +19.1% | +6.1% | +95.4% | — |
| Net income growth | -2.0% | -20.7% | +77.4% | +7.6% | — | — | — | -257.7% | — | — |
| EPS growth | +3.3% | -16.9% | +78.3% | +7.8% | — | — | — | — | — | — |
| Free cash flow growth | -24.5% | -12.6% | +41.9% | +26.9% | +82.0% | +799.5% | — | -114.3% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.